EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual inhibition of MMP-2 and actin dynamics by a novel bis-chalcone: an anticancer strategy for oral squamous cell carcinoma

Rodrigo Elísio de Sá, Bruna Oliveira de Almeida, Marcelo da Costa Mota, Matheus Pedrosa de Oliveira, Anali Del Milagro Bernabe Garnique, Keli Lima, Aline Bernardes Valeze, Jefferson Almeida Rocha, Caridad Noda Pérez, João Agostinho Machado Neto, Letícia Veras Costa Lotufo, José Delano Barreto Marinho Filho und 1 weitere

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05050-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Rodrigo Elísio de Sá und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Cultura de Células do Delta (LCCDelta), Universidade Federal Delta do Parnaíba, UFDPar, Parnaíba, PI, Brazil. Hauptthemen laut MEDLINE: Mouth Neoplasms, Matrix Metalloproteinase 2, Antineoplastic Agents, Chalcones. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, National Institute of Science and Technology - INCT BioNat, National Institute of Science and Technology – INCT BioNat.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral squamous cell carcinoma (OSCC), accounts for approximately 90% of oral cancer cases, and due to its aggressive nature and limited treatment options remains a significant clinical challenge. In the pursuit of novel therapeutic agents, bis-chalcones (a subclass of chalcones) have emerged as promising candidates with multipronged anticancer potential. In this study, we synthesized and evaluated a novel bis-chalcone (B2OCH 3 ), for its cytotoxic, anti-migratory, anti-invasive, and anti-adhesive activities, as well as potential mechanisms of action. The compound was obtained via Claisen–Schmidt condensation and spectroscopically characterized. Cytotoxicity was assessed using MTT, pulse treatment, and trypan blue exclusion assays. Morphological changes were examined with panoptic staining and immunofluorescence. Clonogenic, migration, adhesion, and invasion assays were performed to assess anti-metastatic potential. Molecular docking and gene/protein expression analyses were conducted by quantitative PCR and Western blot. B2OCH 3 exhibited potent cytotoxicity against HSC-3, SCC-4, and CAL-27 OSCC cell lines, with HSC-3 being the most sensitive. The compound demonstrated selectivity for cancer cells as compared with non-tumor HS5 and HaCaT cells. Reduced viability was accompanied by mitotic figures and apoptotic bodies. B2OCH 3 significantly inhibited colony formation, migration, invasion, and adhesion in HSC-3 cells. Morphological analysis revealed modulation of actin filament organization and reduced filopodia formation. Molecular docking indicated MMP-2 and F-actin affinity, and was corroborated by molecular assays confirming protein modulation for both. Our findings identify B2OCH 3 as a promising therapeutic candidate for OSCC, highlighting its potential to simultaneously target both MMP-2 activity and actin cytoskeleton regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsMatrix Metalloproteinase 2Antineoplastic AgentsChalconesCarcinoma, Squamous CellActinsMatrix Metalloproteinase InhibitorsChalconeHumansCell MovementCell Line, TumorMolecular Docking SimulationCell AdhesionCell Survival

Stichwörter der Autor:innen

Cell invasionCell migrationMetalloproteinasesOral squamous cell carcinomaSymmetrical bis-chalcone

Substanzen

Matrix Metalloproteinase 2Antineoplastic AgentsChalconesActinsMMP2 protein, humanMatrix Metalloproteinase InhibitorsChalcone

Autor:innen und Institutionen

  • Laboratório de Cultura de Células do Delta (LCCDelta), Universidade Federal Delta do Parnaíba, UFDPar, Parnaíba, PI, Brazil.
  • Departamento de Farmacologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, USP, São Paulo, SP, Brazil.
  • Grupo de Pesquisa Em Química Medicinal E Biotecnologia (QUIMEBIO), Universidade Federal do Maranhão, UFMA, São Bernardo, MA, Brazil.
  • Departamento de Ensino, Instituto Federal de Educação, Ciência e Tecnologia de Mato Grosso - IFMT, Cuiabá, MT, Brazil.
  • Laboratório de Sínteses Orgânica e Catálise, Instituto de Química, Universidade Federal de Goiás, UFG, Goiânia, GO, Brazil.
  • Laboratório de Cultura de Células do Delta (LCCDelta), Universidade Federal Delta do Parnaíba, UFDPar, Parnaíba, PI, Brazil. anajersia@ufdpar.edu.br.

ORCID-Profile: Ana Jérsia Araújo

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • National Institute of Science and Technology - INCT BioNat
  • National Institute of Science and Technology – INCT BioNat
  • Universidade Federal Do Delta Do Parnaíba

Zitieren

APA

de Sá, R. E., de Almeida, B. O., da Costa Mota, M., de Oliveira, M. P., Del Milagro Bernabe Garnique, A., Lima, K., Valeze, A. B., Rocha, J. A., Pérez, C. N., Machado Neto, J. A., Costa Lotufo, L. V., Marinho Filho, J. D. B., & Araújo, A. J. (2026). Dual inhibition of MMP-2 and actin dynamics by a novel bis-chalcone: an anticancer strategy for oral squamous cell carcinoma. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05050-0

Vancouver

de Sá RE, de Almeida BO, da Costa Mota M, de Oliveira MP, Del Milagro Bernabe Garnique A, Lima K, et al. Dual inhibition of MMP-2 and actin dynamics by a novel bis-chalcone: an anticancer strategy for oral squamous cell carcinoma. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05050-0

BibTeX
@article{deS2026,
  author = {de Sá, Rodrigo Elísio and de Almeida, Bruna Oliveira and da Costa Mota, Marcelo and de Oliveira, Matheus Pedrosa and Del Milagro Bernabe Garnique, Anali and Lima, Keli and Valeze, Aline Bernardes and Rocha, Jefferson Almeida and Pérez, Caridad Noda and Machado Neto, João Agostinho and Costa Lotufo, Letícia Veras and Marinho Filho, José Delano Barreto and Araújo, Ana Jérsia},
  title = {Dual inhibition of MMP-2 and actin dynamics by a novel bis-chalcone: an anticancer strategy for oral squamous cell carcinoma},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05050-0}
}
Kostenlos starten →